Monoclonal gammopathy of renal significance triggering atypical haemolytic uraemic syndrome
Journal Contribution ResearchOnline@JCUAbstract
Haemolytic uraemic syndrome is a rare condition with an overall incidence ofone to two cases in a population of 100 000 and approximately 10% of thesecases are classified as atypical.1Atypical haemolytic uraemic syndrome (aHUS)is a thrombotic microangiopathy (TMA) characterized by microangiopathichaemolytic anaemia (MAHA), thrombocytopenia and acute kidney injury.aHUS can be genetic, acquired or idiopathic (negative genetic screening andno environmental triggers). We describe a case of aHUS triggered by monoclo-nal gammopathy of renal significance (MGRS) successfully treated with plas-mapheresis and a bortezomib-based chemotherapy regimen, resulting inmarked improvement in renal function and other markers of haemolysis. Thispatient has been in remission for more than 2 years currently.
Journal
Nephrology
Publication Name
N/A
Volume
22
ISBN/ISSN
1440-1797
Edition
N/A
Issue
Suppl. 1
Pages Count
3
Location
N/A
Publisher
Wiley-Blackwell Publishing Asia
Publisher Url
N/A
Publisher Location
N/A
Publish Date
N/A
Url
N/A
Date
N/A
EISSN
N/A
DOI
10.1111/nep.12934